IndinavirLamivudineStavudineOrganophosphonatesAnti-HIV AgentsHepatitis B, ChronicHIV Protease InhibitorsZidovudineAdenineDrug Therapy, CombinationReverse Transcriptase InhibitorsAntiviral AgentsHIV InfectionsRitonavirHIV-1Hepatitis B virusSaquinavirDrug Resistance, ViralNelfinavirHepatitis B e AntigensInterferon-alphaTreatment OutcomeBenzoxazinesOxazinesDideoxynucleosidesPyrimidinonesViral LoadNevirapineHepatitis BDidanosineLopinavirArea Under CurveCD4 Lymphocyte CountAntiretroviral Therapy, Highly ActiveDrug InteractionsDNA, ViralHIV ProteaseAlanine TransaminaseDrug Administration ScheduleTreatment FailureHepatitis B Surface AntigensCarbamatesRNA, ViralPyuriaHIV Reverse TranscriptaseCytochrome P-450 CYP3ANucleosidesMutationDrug Resistance, Multiple, ViralDouble-Blind MethodDrug CombinationsHepatitis B AntibodiesGene Products, polSophoraAnti-Retroviral AgentsRecurrenceGuanineZalcitabineDrug Resistance, MicrobialTime FactorsLiver TransplantationDrug MonitoringAdministration, OralDose-Response Relationship, DrugAntineoplastic Combined Chemotherapy Protocols